These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 25189159)
1. Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy. Yoshikawa T; Takahara M; Tomiyama M; Nieda M; Maekawa R; Nakatsura T Int J Oncol; 2014 Nov; 45(5):1847-56. PubMed ID: 25189159 [TBL] [Abstract][Full Text] [Related]
2. Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens. Altvater B; Pscherer S; Landmeier S; Kailayangiri S; Savoldo B; Juergens H; Rossig C Cancer Immunol Immunother; 2012 Mar; 61(3):385-96. PubMed ID: 21928126 [TBL] [Abstract][Full Text] [Related]
3. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925 [TBL] [Abstract][Full Text] [Related]
4. A single bout of dynamic exercise enhances the expansion of MAGE-A4 and PRAME-specific cytotoxic T-cells from healthy adults. LaVoy EC; Bollard CM; Hanley PJ; Blaney JW; O'Connor DP; Bosch JA; Simpson RJ Exerc Immunol Rev; 2015; 21():144-53. PubMed ID: 25826370 [TBL] [Abstract][Full Text] [Related]
5. [Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma]. Nishimura Y; Nakatsura T; Senju S Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):383-91. PubMed ID: 18974622 [TBL] [Abstract][Full Text] [Related]
6. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy. Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372 [TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Komori H; Nakatsura T; Senju S; Yoshitake Y; Motomura Y; Ikuta Y; Fukuma D; Yokomine K; Harao M; Beppu T; Matsui M; Torigoe T; Sato N; Baba H; Nishimura Y Clin Cancer Res; 2006 May; 12(9):2689-97. PubMed ID: 16675560 [TBL] [Abstract][Full Text] [Related]
8. Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers. Savage P; Millrain M; Dimakou S; Stebbing J; Dyson J Tumour Biol; 2007; 28(2):70-6. PubMed ID: 17264539 [TBL] [Abstract][Full Text] [Related]
9. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy. Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033 [TBL] [Abstract][Full Text] [Related]
10. Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice. Nakatsura T; Komori H; Kubo T; Yoshitake Y; Senju S; Katagiri T; Furukawa Y; Ogawa M; Nakamura Y; Nishimura Y Clin Cancer Res; 2004 Dec; 10(24):8630-40. PubMed ID: 15623647 [TBL] [Abstract][Full Text] [Related]
11. Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes. Sawada Y; Yoshikawa T; Shimomura M; Iwama T; Endo I; Nakatsura T Int J Oncol; 2015 Jan; 46(1):28-36. PubMed ID: 25354479 [TBL] [Abstract][Full Text] [Related]
13. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation. Nada MH; Wang H; Workalemahu G; Tanaka Y; Morita CT J Immunother Cancer; 2017; 5():9. PubMed ID: 28239463 [TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro. Fujie T; Tanaka F; Mori M; Takesako K; Sugimachi K; Akiyoshi T Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2425-30. PubMed ID: 9815643 [TBL] [Abstract][Full Text] [Related]
15. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads. Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928 [TBL] [Abstract][Full Text] [Related]
16. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice. Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074 [TBL] [Abstract][Full Text] [Related]
17. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes. Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice. Iwama T; Uchida T; Sawada Y; Tsuchiya N; Sugai S; Fujinami N; Shimomura M; Yoshikawa T; Zhang R; Uemura Y; Nakatsura T Biochem Biophys Res Commun; 2016 Jan; 469(1):138-143. PubMed ID: 26616051 [TBL] [Abstract][Full Text] [Related]
19. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Gottschalk S; Edwards OL; Sili U; Huls MH; Goltsova T; Davis AR; Heslop HE; Rooney CM Blood; 2003 Mar; 101(5):1905-12. PubMed ID: 12411306 [TBL] [Abstract][Full Text] [Related]
20. Induction of antiviral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of posttransplant diseases. Aspord C; Laurin D; Richard MJ; Vie H; Chaperot L; Plumas J Am J Transplant; 2011 Dec; 11(12):2613-26. PubMed ID: 21883919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]